Lila Hollin Green established this lectureship to foster the memory of her late husband, Dr. Sidney A. Hollin, a well-known cerebrovascular neurosurgeon at Mount Sinai. After completing a residency in Neurosurgery at Mount Sinai, Dr. Hollin continued as a traveling fellowship in Neuropathology at the National Hospital for Neurology and Neurosurgery, Queen Square, London, and training in Neurology at Atkinson Morley’s Hospital in Wimbledon, England. Dr. Hollin returned to Elmhust Hospital from 1961-1979 and served as Director of the Neurosurgical Service from 1974 until 1979 and also held an appointment at Mount Sinai School of Medicine from 1966 until his retirement in 1983.
Building a Brain Tumor Center
Ricardo Jorge Komotar, MD, FAANS, FACS, is an Associate Professor of Neurological Surgery at the University of Miami School of Medicine. He graduated summa cum laude with a B.S. in neuroscience from Duke University, spending a year at Oxford University in England to focus on neuropharmacology. He received his medical degree from The Johns Hopkins University School of Medicine with highest honors and completed his internship and neurosurgical residency at Columbia University Medical Center/The Neurological Institute of New York, followed by a surgical neurooncology fellowship at Memorial Sloan-Kettering Cancer Center to specialize in brain tumors.
As Director of the University of Miami Brain Tumor Initiative, Director of Surgical Neurooncology at the University of Miami, Director of the UM Neurosurgery Residency Program, and Director of the UM Surgical Neurooncology Fellowship Program, Dr. Komotar’s main clinical interests are surgical and radiosurgical (Gamma Knife) treatment of primary and metastatic brain tumors, as well as meningiomas and pituitary lesions. Dr. Komotar is an internationally recognized leader in the field of brain tumors and performs nearly 700 procedures for these conditions each year using advanced cutting-edge surgical/radiosurgical techniques, making him one of the highest volume brain tumor surgeons in the world.
His research interests include clinical trial development and translational neurooncologic investigations designed to pioneer new therapies for brain tumors. Author of over 500 peer reviewed scientific articles, book chapters, and invited editorials, Dr. Komotar has received research funding from the National Institutes of Health as well as other national and regional grants. He has served on the Executive Committee for the Congress of Neurological Surgeons and the Executive Board for the AANS/CNS Joint Section on Tumors. He is Founder and Director of the Annual Neurosurgery Charity Softball Tournament to benefit brain tumor research. He is a member of the Society of Neurooncology and reviewer for both Neurosurgery and the Journal of Neurosurgery. Dr. Komotar is also an Emmy ® nominated physician for his work on the series “Breakthrough Medicine.”
Wednesday, October 31, 2018 at 8:00am to 8:45am